A citation-based method for searching scientific literature

M Sedeek, G Callera, A Montezano, A Gutsol, F Heitz, C Szyndralewiez, P Page, C R J Kennedy, K D Burns, R M Touyz, R L Hébert. Am J Physiol Renal Physiol 2010
Times Cited: 274







List of co-cited articles
1195 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



Genetic targeting or pharmacologic inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy.
Jay C Jha, Stephen P Gray, David Barit, Jun Okabe, Assam El-Osta, Tamehachi Namikoshi, Vicki Thallas-Bonke, Kirstin Wingler, Cedric Szyndralewiez, Freddy Heitz,[...]. J Am Soc Nephrol 2014
216
26

Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.
Yves Gorin, Karen Block, James Hernandez, Basant Bhandari, Brent Wagner, Jeffrey L Barnes, Hanna E Abboud. J Biol Chem 2005
398
19

Targeting NADPH oxidase with a novel dual Nox1/Nox4 inhibitor attenuates renal pathology in type 1 diabetes.
Yves Gorin, Rita C Cavaglieri, Khaled Khazim, Doug-Yoon Lee, Francesca Bruno, Sachin Thakur, Paolo Fanti, Cédric Szyndralewiez, Jeffrey L Barnes, Karen Block,[...]. Am J Physiol Renal Physiol 2015
112
18

NADPH oxidases, reactive oxygen species, and the kidney: friend and foe.
Mona Sedeek, Rania Nasrallah, Rhian M Touyz, Richard L Hébert. J Am Soc Nephrol 2013
239
16

Renoprotective effects of a novel Nox1/4 inhibitor in a mouse model of Type 2 diabetes.
Mona Sedeek, Alex Gutsol, Augusto C Montezano, Dylan Burger, Aurelie Nguyen Dinh Cat, Chris R J Kennedy, Kevin D Burns, Mark E Cooper, Karin Jandeleit-Dahm, Patrick Page,[...]. Clin Sci (Lond) 2013
119
14

Identification of renox, an NAD(P)H oxidase in kidney.
M Geiszt, J B Kopp, P Várnai, T L Leto. Proc Natl Acad Sci U S A 2000
641
14

Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease.
Stephen P Gray, Jay C Jha, Kit Kennedy, Erik van Bommel, Phyllis Chew, Cedric Szyndralewiez, Rhian M Touyz, Harald H H W Schmidt, Mark E Cooper, Karin A M Jandeleit-Dahm. Diabetologia 2017
60
23

NADPH Oxidase Nox5 Accelerates Renal Injury in Diabetic Nephropathy.
Jay C Jha, Claudine Banal, Jun Okabe, Stephen P Gray, Thushan Hettige, Bryna S M Chow, Vicki Thallas-Bonke, Lisanne De Vos, Chet E Holterman, Melinda T Coughlan,[...]. Diabetes 2017
76
18

NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.
Stephen P Gray, Elyse Di Marco, Jun Okabe, Cedric Szyndralewiez, Freddy Heitz, Augusto C Montezano, Judy B de Haan, Christine Koulis, Assam El-Osta, Karen L Andrews,[...]. Circulation 2013
247
13

First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.
Benoît Laleu, Francesca Gaggini, Mike Orchard, Laetitia Fioraso-Cartier, Laurène Cagnon, Sophie Houngninou-Molango, Angelo Gradia, Guillaume Duboux, Cédric Merlot, Freddy Heitz,[...]. J Med Chem 2010
170
13

Nephropathy and elevated BP in mice with podocyte-specific NADPH oxidase 5 expression.
Chet E Holterman, Jean-François Thibodeau, Chelsea Towaij, Alex Gutsol, Augusto C Montezano, Robin J Parks, Mark E Cooper, Rhian M Touyz, Christopher R J Kennedy. J Am Soc Nephrol 2014
80
16

NADPH oxidases in the kidney.
Pritmohinder S Gill, Christopher S Wilcox. Antioxid Redox Signal 2006
361
13

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.
Tomonori Aoyama, Yong-Han Paik, Sumio Watanabe, Benoît Laleu, Francesca Gaggini, Laetitia Fioraso-Cartier, Sophie Molango, Freddy Heitz, Cédric Merlot, Cédric Szyndralewiez,[...]. Hepatology 2012
198
12

Oxidative stress as a major culprit in kidney disease in diabetes.
Josephine M Forbes, Melinda T Coughlan, Mark E Cooper. Diabetes 2008
739
12

Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
Jay C Jha, Vicki Thallas-Bonke, Claudine Banal, Stephen P Gray, Bryna S M Chow, Georg Ramm, Susan E Quaggin, Mark E Cooper, Harald H H W Schmidt, Karin A Jandeleit-Dahm. Diabetologia 2016
75
16

Subcellular localization of Nox4 and regulation in diabetes.
Karen Block, Yves Gorin, Hanna E Abboud. Proc Natl Acad Sci U S A 2009
338
12

Diabetes and Kidney Disease: Role of Oxidative Stress.
Jay C Jha, Claudine Banal, Bryna S M Chow, Mark E Cooper, Karin Jandeleit-Dahm. Antioxid Redox Signal 2016
175
12

Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase.
Katrin Schröder, Min Zhang, Sebastian Benkhoff, Anja Mieth, Rainer Pliquett, Judith Kosowski, Christoph Kruse, Peter Luedike, U Ruth Michaelis, Norbert Weissmann,[...]. Circ Res 2012
417
11

Evolution of NADPH Oxidase Inhibitors: Selectivity and Mechanisms for Target Engagement.
Sebastian Altenhöfer, Kim A Radermacher, Pamela W M Kleikers, Kirstin Wingler, Harald H H W Schmidt. Antioxid Redox Signal 2015
294
11

Role of Nox2 in diabetic kidney disease.
Young-Hyun You, Shinichi Okada, San Ly, Karin Jandeleit-Dahm, David Barit, Tamehachi Namikoshi, Kumar Sharma. Am J Physiol Renal Physiol 2013
65
16


Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5.
G Cheng, Z Cao, X Xu, E G van Meir, J D Lambeth. Gene 2001
644
10

Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.
T Nishikawa, D Edelstein, X L Du, S Yamagishi, T Matsumura, Y Kaneda, M A Yorek, D Beebe, P J Oates, H P Hammes,[...]. Nature 2000
10

Therapeutic potential of NADPH oxidase 1/4 inhibitors.
G Teixeira, C Szyndralewiez, S Molango, S Carnesecchi, F Heitz, P Wiesel, J M Wood. Br J Pharmacol 2017
90
10

The E-loop is involved in hydrogen peroxide formation by the NADPH oxidase Nox4.
Ina Takac, Katrin Schröder, Leilei Zhang, Bernard Lardy, Narayana Anilkumar, J David Lambeth, Ajay M Shah, Francoise Morel, Ralf P Brandes. J Biol Chem 2011
346
9


A novel superoxide-producing NAD(P)H oxidase in kidney.
A Shiose, J Kuroda, K Tsuruya, M Hirai, H Hirakata, S Naito, M Hattori, Y Sakaki, H Sumimoto. J Biol Chem 2001
405
9

Novel Nox inhibitor VAS2870 attenuates PDGF-dependent smooth muscle cell chemotaxis, but not proliferation.
Henrik ten Freyhaus, Michael Huntgeburth, Kirstin Wingler, Jessika Schnitker, Anselm T Bäumer, Marius Vantler, Mohamed M Bekhite, Maria Wartenberg, Heinrich Sauer, Stephan Rosenkranz. Cardiovasc Res 2006
207
9


AMP-activated protein kinase (AMPK) negatively regulates Nox4-dependent activation of p53 and epithelial cell apoptosis in diabetes.
Assaad A Eid, Bridget M Ford, Karen Block, Balakuntalam S Kasinath, Yves Gorin, Goutam Ghosh-Choudhury, Jeffrey L Barnes, Hanna E Abboud. J Biol Chem 2010
185
9

Nox-4 deletion reduces oxidative stress and injury by PKC-α-associated mechanisms in diabetic nephropathy.
Vicki Thallas-Bonke, Jay C Jha, Stephen P Gray, David Barit, Hermann Haller, Harald H H W Schmidt, Melinda T Coughlan, Mark E Cooper, Josephine M Forbes, Karin A M Jandeleit-Dahm. Physiol Rep 2014
67
13

Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.
Christoph Kleinschnitz, Henrike Grund, Kirstin Wingler, Melanie E Armitage, Emma Jones, Manish Mittal, David Barit, Tobias Schwarz, Christian Geis, Peter Kraft,[...]. PLoS Biol 2010
303
8

The NOX toolbox: validating the role of NADPH oxidases in physiology and disease.
Sebastian Altenhöfer, Pamela W M Kleikers, Kim A Radermacher, Peter Scheurer, J J Rob Hermans, Paul Schiffers, Heidi Ho, Kirstin Wingler, Harald H H W Schmidt. Cell Mol Life Sci 2012
249
8

Metabolomics Reveals a Key Role for Fumarate in Mediating the Effects of NADPH Oxidase 4 in Diabetic Kidney Disease.
Young-Hyun You, Tammy Quach, Rintaro Saito, Jessica Pham, Kumar Sharma. J Am Soc Nephrol 2016
105
8

The NOX1/4 inhibitor GKT136901 as selective and direct scavenger of peroxynitrite.
S Schildknecht, A Weber, H R Gerding, R Pape, M Robotta, M Drescher, A Marquardt, A Daiber, B Ferger, M Leist. Curr Med Chem 2014
34
23

A key role for NOX4 in epithelial cell death during development of lung fibrosis.
Stephanie Carnesecchi, Christine Deffert, Yves Donati, Olivier Basset, Boris Hinz, Olivier Preynat-Seauve, Cecile Guichard, Jack L Arbiser, Botond Banfi, Jean-Claude Pache,[...]. Antioxid Redox Signal 2011
187
8

Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.
Assaad A Eid, Yves Gorin, Bridget M Fagg, Rita Maalouf, Jeffrey L Barnes, Karen Block, Hanna E Abboud. Diabetes 2009
209
8

Functional analysis of Nox4 reveals unique characteristics compared to other NADPH oxidases.
Kendra D Martyn, Linda M Frederick, Katharina von Loehneysen, Mary C Dinauer, Ulla G Knaus. Cell Signal 2006
564
8

Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.
S Wind, K Beuerlein, T Eucker, H Müller, P Scheurer, M E Armitage, H Ho, H H H W Schmidt, K Wingler. Br J Pharmacol 2010
178
8

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.
Dick de Zeeuw, Tadao Akizawa, Paul Audhya, George L Bakris, Melanie Chin, Heidi Christ-Schmidt, Angie Goldsberry, Mark Houser, Melissa Krauth, Hiddo J Lambers Heerspink,[...]. N Engl J Med 2013
566
8

AMPK dysregulation promotes diabetes-related reduction of superoxide and mitochondrial function.
Laura L Dugan, Young-Hyun You, Sameh S Ali, Maggie Diamond-Stanic, Satoshi Miyamoto, Anne-Emilie DeCleves, Aleksander Andreyev, Tammy Quach, San Ly, Grigory Shekhtman,[...]. J Clin Invest 2013
282
8

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
8

A Ca(2+)-activated NADPH oxidase in testis, spleen, and lymph nodes.
B Bánfi, G Molnár, A Maturana, K Steger, B Hegedûs, N Demaurex, K H Krause. J Biol Chem 2001
444
8

Endothelial Nox4 NADPH oxidase enhances vasodilatation and reduces blood pressure in vivo.
Robin Ray, Colin E Murdoch, Minshu Wang, Celio X Santos, Min Zhang, Sara Alom-Ruiz, Narayana Anilkumar, Alexandre Ouattara, Alison C Cave, Simon J Walker,[...]. Arterioscler Thromb Vasc Biol 2011
221
7

Nox proteins in signal transduction.
David I Brown, Kathy K Griendling. Free Radic Biol Med 2009
578
7

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury.
Louise Hecker, Ragini Vittal, Tamara Jones, Rajesh Jagirdar, Tracy R Luckhardt, Jeffrey C Horowitz, Subramaniam Pennathur, Fernando J Martinez, Victor J Thannickal. Nat Med 2009
567
7

Novel mechanism of activation of NADPH oxidase 5. calcium sensitization via phosphorylation.
Davin Jagnandan, Jarrod E Church, Botond Banfi, Dennis J Stuehr, Mario B Marrero, David J R Fulton. J Biol Chem 2007
153
7


Poldip2, a novel regulator of Nox4 and cytoskeletal integrity in vascular smooth muscle cells.
Alicia N Lyle, Nita N Deshpande, Yoshihiro Taniyama, Bonnie Seidel-Rogol, Lily Pounkova, Pingfeng Du, Christopher Papaharalambus, Bernard Lassègue, Kathy K Griendling. Circ Res 2009
310
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.